27. Bagalkot V, Zhang L, Levy-Nissenbaum E, et al. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-ﬂuorescence resonance energy transfer. Nano Lett. 2007;7:3065–3070. 28. Derfus AM, Chan WCW, Bhatia SN. Probing the cytotoxicity of semi- conductor quantum dots. Nano Lett. 2004;4:11–18. 29. Cho SJ, Maysinger D, Jain M, Roder B, Hackbarth S, Winnik FM. Long-term exposure to CdTe quantum dots causes functional impair- ments in live cells. Langmuir. 2007;23:1974–1980. 30. Green M, Howman E. Semiconductor quantum dots and free radical induced DNA nicking. Chem Commun (Camb). 2005;1:121–123. 31. Choi AO, Cho SJ, Desbarats J, Lovric J, Maysinger D. Quantum dot- induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells. J Nanobiotechnology. 2007;5:1. 32. Lovric J, Cho SJ, Winnik FM, Maysinger D. Unmodiﬁed cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death. Chem Biol. 2005;12:1159–1161. 33. Frangioni JV. In vivo near-infrared ﬂuorescence imaging. Curr Opin Chem Biol. 2003;7:626–634. 34. Parungo CP, Colson YL, Kim SW, et al. Sentinel lymph node mapping of the pleural space. Chest. 2005;127:1799–1804. 35. Parungo CP, Ohnishi S, Kim SW, et al. Intraoperative identiﬁcation of esophageal sentinel lymph nodes with nearinfrared ﬂuorescence imaging. J Thorac Cardiovasc Surg. 2005;129:844–850. 36. Tomalia DA, Dewald JR; The Dow Chemical Corporation (Midland, MI). Dense star polymers having core, core branches, terminal groups; United States patent US 4,507,466. 1985 March 26. 37. Tomalia DA, Baker H, Dewald J, et al. Anew class of polymer:starburst- dendritic macromolecules. Polym J. 1985;17:117–132. 38. Hawker CJ, Fre´chet JMJ. Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic mac- romolecules, J Am Chem Soc. 1990;112:7638–7647. 39. Tomalia DA. Birth of a new macromolecular architecture:dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry. Prog Polym Sci. 2005;30(3–4):294–324. 40. Bai S, Thomas C, Rawat A, Ahsan F. Recent progress in dendrimer-based nanocarriers. Crit Rev Ther Drug Carrier Syst. 2006;23:437–495. 41. Gillies ER, Frechet JM. Dendrimers and dendritic polymers in drug delivery. Drug Discov Today. 2005;10:35–43. 42. Tomalia DA, Reyna LA, Svenson S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem Soc Trans. 2007;35(Pt 1):61–67. 43. Padilla De Jesús OL, Ihre HR, Gagne L, Fréchet JM, Szoka FC Jr. Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation. Bioconjug Chem. 2002;13:453–461. 44. Lai PS, Lou PJ, Peng CL, et al. Doxorubicin delivery by polyamido- amine dendrimer conjugation and photochemical internalization for cancer therapy. J Control Release. 2007;122:39–46. 45. Malik N, Evagorou EG, Duncan R. Dendrimer-platinate: a novel approach to cancer chemotherapy. Anticancer Drugs. 1999;10:767–776. 46. Zhuo RX, Du B, Lu ZR. In vitro release of 5-ﬂuorouracil with cyclic core dendritic polymer. J Control Release. 1999;57:249–257. 47. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular perme- ability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000;65(1–2):271–284. 48. Lee CC, Gillies ER, Fox ME et al. A single dose of doxorubicin- functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas. Proc Natl Acad Sci U S A. 2006;103:16649–16654. Nanoparticles and cancer therapy 49. Bhadra D, Bhadra S, Jain S, Jain NK. A PEGylated dendritic nanoparticulate carrier of ﬂuorouracil. Int J Pharm. 2003;257(1–2): 111–124. 50. Lu Y, Low PS. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev. 2002;54:675–693. 51. Patri AK, Kukowska-Latallo JF, Baker JR Jr. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug ad non-covalent drug inclusion complex. Adv Drug Deliv Rev. 57:2203–2214. 52. Quintana A, Raczka E, Piehler L, et al. Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res. 2002;19:1310–1316. 53. Kobayashi H, Brechbiel MW. Dendrimer-based macromolecular MRI contrast agents: characteristics and application. Mol Imaging. 2003;2:1–10. 54. Choi HC, Kim W, Wang D , Dai H. Delivery of catalytic metal species onto surfaces with dendrimer carriers for the synthesis of carbon nanotubes with narrow diameter distribution. J Phys Chem B. 2002;106:12361–12365. 55. Amama PB, Ogebule O, Maschmann MR, Sands TD, Fisher TS. Dendrimer-assisted low-temperature growth of carbon nanotubes by plasma-enhanced chemical vapor deposition. Chem Commun (Camb). 2006; (27):2899–2901. 56. Pan BF, Cui· DX, Xu P , et al. Cellular uptake enhancement of polyami- doamine dendrimer modiﬁed single walled carbon nanotubes. J. Biomed Pharm Eng. 2007;1:13–16. 57. Wu P, Chen X, Hu N, et al. Biocompatible carbon nanotubes generated by functionalization with glycodendrimers. Angew Chem Int Ed Engl. 2008;47:5022–5025. 58. Dunford R, Salinaro A, Cai L, et al. Chemical oxidation and DNA damage catalysed by inorganic sunscreen ingredients. FEBS Lett. 1997;418(1–2):87–90. 59. Wootliff B. Bristish Scientist: Nanoparticles might move from mom to Fetus. Small Times. [Cited Jan 14, 2004]. Available from: http://www. smalltimes.com/articles/article_display.cfm?Section=ARCHI&C= Bio&ARTICLE_ID=269201&p=109. 60. Shvedova AA, Castranova V, Kisin ER, et al. Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health A. 2003;66:1909–1926. 61. Shvedova AA, Kisin E, Murray AR. Exposure of human bronchial cells to carbon nanotubes caused oxidative stress and cytotoxicity. Proc Soc Free Rad Research Meeting, European Section: Taylor and Francis Group; 2004. 62. Lam CW, James JT, McCluskey R, Hunter RL. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci. 2004;77:126–134. 63. Lam PK, Chan ES, Ho WS, Liew CT. In vitro cytotoxicity testing of a nanocrystalline silver dressing (Acticoat) on cultured keratinocytes. Br J Biomed Sci. 2004;61:125–127. 64. Poon VK, Burd A. In vitro cytotoxity of silver: implication for clinical wound care. Burns. 2004;30:140–147. 65. Maynard AD. Nanotechnology: a research strategy for addressing risks. Woodrow Wilson International Center for Scholars: Project on emerg- ing nanotechnologies. 2006. [Cited on Nov 10, 2008]. Available from: http://www.nanotechproject.org/ﬁle_download/ﬁles/PEN3_Risk.pdf. International Journal of Nanomedicine 2009:4 7